BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

IBP

All Eps Dividend Board Agm Q1 Q2 Q3

IBP 16-Nov-2021

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 17.11.2021 to 18.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 21.11.2021.

IBP 15-Nov-2021

Record Date of the company will be 21.11.2021 instead of 17.11.2021; AGM Date will be: 23.12.2021. Time: 11.00 AM. Spot date will be 17.11.2021 and 18.11.2021 instead of 15.11.2021 and 16.11.2021. Therefore, all transaction will be in public/block market on today 15.11.2021 and tomorrow 16.11.2021. All other information will remain unchanged.

IBP 15-Nov-2021

(Q1 Un-audited): EPS was Tk. 0.34 for July-September, 2021 as against Tk. 0.33 for July-September, 2020. NOCFPS was Tk. 0.42 for July-September, 2021 as against Tk. 0.23 for July-September, 2020. NAV per share was Tk. 14.63 as on September 30, 2021 and Tk. 14.29 as on June 30, 2021.

IBP 14-Nov-2021

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 15.11.2021 to 16.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 17.11.2021.

IBP 08-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

IBP 31-Oct-2021

There will be no price limit on the trading of the shares of the Company today (31.10.2021) following its corporate declaration.

IBP 31-Oct-2021

(Cont. of IBP): b. Bonus shares are declared out of accumulated profit. c. Bonus shares are not declared from capital reserve on revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the company or through reducing paid up capital or through doing anything so that the post dividend retained earnings become negative or a debit balance. (end)

IBP 31-Oct-2021

(Cont. of IBP):The Company has reported EPS of Tk. 1.18, NAV per share of Tk. 14.29 and NOCFPS of Tk. 1.33 for the year ended on June 30, 2021 as against Tk. 1.37, Tk. 13.61 and Tk. 1.54 respectively for the same period of the previous year. a. Bonus Shares and partial distribution of profit as dividend have been recommended in view to utilize its retained amount as capital for further business expansion, development of 2nd unit specially for antibiotic and cephalosporin as well as working capital.(Cont.3)

IBP 31-Oct-2021

(Cont. of IBP): Such Stock Dividend subject to approval of BSEC. New Record date for entitlement of Stock Dividend will be notified later after getting approval from BSEC as per BSEC Notification No. BSEC/CMRRCD/2009-193/23/Admin /123; Dated June 30, 2021. (Cont.2)

IBP 31-Oct-2021

The Board of Directors has recommended 4% Cash dividend (Excluding sponsor and Director) and 3% Stock Dividend for General Shareholders and ICB Excluding sponsors and Directors) for the year ended on June 30, 2021. Sponsors and Directors hold 43.82% share and General shareholders hold 56.17 share and taka 25.56 million will be paid as dividend. Date of AGM: December 13, 2021, Time: 11:30 AM, Venue: Digital Platform. Record Date: November 17, 2021. (Cont.1)

Previous Next page